MIDDLESEX GASES & TECHNOLOGIES INC. v. FLYALS LTD
- Citation
- [2025] HKCFI 2798
- Status
- Judgment
- Jurisdiction
- Hong Kong
- Court
- Court of First Instance
- Decision
- 27 June 2025
- Posture
- Application for Continuation of Mareva and Proprietary Injunction; Norwich Pharmacal and S.21 Evidence Ordinance Disclosure / Return Date (interim Hearing)
- Case number
- HCA1158/2025
- Language
- English
More details
- Court
- Court of First Instance
- Decision
- 27 June 2025
- Posture
- Application for Continuation of Mareva and Proprietary Injunction; Norwich Pharmacal and S.21 Evidence Ordinance Disclosure / Return Date (interim Hearing)
- Case number
- HCA1158/2025
- Language
- English
On this page
Professional case brief
Research organized from the available case record
01
Holding and result
The court found P had made out a good arguable case and satisfied the requirements for Norwich Pharmacal and s.21 EO disclosure: the disclosure sought was specific, likely to lead to preservation or discovery of assets, and proportionate. Consequently the Disclosure Summons as amended was granted and the Mareva and proprietary injunction was continued until trial or further order to preserve P's claimed assets.
Court disposition
Disclosure order granted; Mareva and proprietary injunction continued until trial or further order
Orders
- Continuation of the Mareva and proprietary injunction until trial or further order of the court
- Disclosure order in terms of the Disclosure Summons as amended: Bank to disclose D's account opening documents, related supporting documents and details of all transactions in respect of D's account from 20 May 2025 to date of order
- Ancillary disclosure orders to enable P to locate, trace and preserve assets
02
Material facts
Parties
P (Massachusetts company, subsidiary of Linde Gas & Equipment Inc.)
Plaintiff Counsel: Mr Kevin LauD (Defendant)
DefendantChina Citic Bank International Limited
BankAmounts and remedies
- Unstopped Transfer: USD 596,000
- Amount Frozen in D's Account (approximate): HKD 4,000,000
- Number of Unauthorised Transfers Observed: 8
03
Procedural history
Posture
Application for Continuation of Mareva and Proprietary Injunction; Norwich Pharmacal and S.21 Evidence Ordinance Disclosure / Return Date (interim Hearing)
04
Questions and positions
Legal issues
- 01
Whether Norwich Pharmacal relief and/or s.21 Evidence Ordinance disclosure should be granted against the Bank in aid of P's proprietary/ tracing claim
- 02
Whether P has established a serious issue to be tried and sufficient prima facie evidence of fraud to justify disclosure and continuation of injunctions
- 03
Whether the disclosure sought is sufficiently specific and proportionate
- 04
Whether the Mareva and proprietary injunction should be continued pending trial
Party arguments
- Applicant
- P alleges a successful fraud resulting in unauthorised transfers from its account, including an unstopped transfer of US$596,000 to D's account. P says there is a good arguable case, the Norwich Pharmacal and s.21 EO criteria are met, the disclosure sought (account opening documents, supporting documents and transaction details from 20 May 2025 to date) is specific and likely to lead to preservation or discovery of assets, and continuation of Mareva and proprietary injunction is necessary to protect recoverable assets.
- Respondent
- D did not appear and did not contest continuation. The Bank, served, indicated 'no stance' on the Disclosure Summons and sought more time to produce documents; there was no contested argument before the court.
05
Court’s reasoning
Legal principles
- 01
A Co v B Co [2002] 3 HKLRD 111
Norwich Pharmacal relief is exceptional and requires cogent and compelling evidence of wrongdoing, necessity of disclosure for tracing/preservation and that disclosure is specific and not unduly wide
- 02
CTO (HK) Ltd v Li Man Chiu [2002] 2 HKLRD 875; Hwang Joon Sang v Golden Electronics Inc. (No 2) [2021] 2 HKLRD 87
s.21 Evidence Ordinance disclosure justified where there is a real prospect the information will lead to location or preservation of assets, documents must be identified with specificity and the court balances advantage against invasion of privacy/confidentiality
- 03
Canton Plus Enterprise Limited & Anor v Tong Zhenjun & Ors [2021] HKCFI 181
A Mareva injunction is to protect a plaintiff from the risk of there being nothing or insufficient assets to enforce a future judgment; ancillary disclosure is appropriate to locate and preserve assets
06
Ratio, limits and disposition
Ratio decidendi
The court found P had made out a good arguable case and satisfied the requirements for Norwich Pharmacal and s.21 EO disclosure: the disclosure sought was specific, likely to lead to preservation or discovery of assets, and proportionate. Consequently the Disclosure Summons as amended was granted and the Mareva and proprietary injunction was continued until trial or further order to preserve P's claimed assets.
Obiter and limits
- Disclosure may involve breach of confidentiality and potential civil or criminal exposure for an innocent intermediary and the court must balance those interests against the plaintiff's need
- Continuation of ancillary disclosure orders routinely follows where a Mareva or proprietary injunction is continued to ensure the injunctions are effective
Court disposition
Disclosure order granted; Mareva and proprietary injunction continued until trial or further order
- Continuation of the Mareva and proprietary injunction until trial or further order of the court
- Disclosure order in terms of the Disclosure Summons as amended: Bank to disclose D's account opening documents, related supporting documents and details of all transactions in respect of D's account from 20 May 2025 to date of order
- Ancillary disclosure orders to enable P to locate, trace and preserve assets
Source and reliance status
Court of First Instance · 27 June 2025
This page organises the available record for research. Confirm quotations, current status, and subsequent treatment against the official source before relying on the case.
Judgment reading view
Judgment text
The complete available source text.
Court of First Instance
Judgment· 27 June 2025
bjbj N gP
CHINA CITIC BANK INTERNATIONAL LIMITED Bank ______ Before: Deputy High Court Judge Grace Chow in Chambers (Open to Public) Date of Hearing: 27 June 2025 Date of Decision: 27 June 2025
DECISION Introduction and Background On 19 June 2025, following an ex parte hearing before Recorder Eugene Fung SC, the Plaintiff ( ) obtained a Mareva and proprietary injunction against the Defendant ( the Injunction Order ). P, a Massachusetts USA company, carries on the business of selling industrial gases across several states of the USA. It is a wholly owned subsidiary of Linde Gas & Equipment Inc. which is an indirect subsidiary of Linde Plc, a publicly traded company with holdings spanning more than 80 countries and is a leading global industrial gas and engineering company. According to P, on 20 May 2025, a fraudster claiming to be a member of P s bank called P s treasurer and convinced the treasurer to access a scam website to check suspected fraudulent transactions. This scam website had a URL link and appearance similar to the real website of the bank. The treasurer was prompted to enter P s e-banking login number and password onto the scam website, allegedly to decline the suspected fraudulent transactions. However, after doing so, the treasurer grew suspicious and amongst other things, logged onto the genuine e-banking website, where he notice a total of 8 unauthorised transfers being made out of P s account to D s account ( s Account ) maintained with China Citic Bank International Limited ( the Bank ). 7 of those transfers were recalled but the last one being the
transfer of US$596,000 to D s Account could not be stopped. P reported the fraud to the authorities including the Hong Kong Police and was informed that D s Account had been frozen and there was about HK$4M left therein. Today is the return date of the Injunction Order. I have before me the following applications by P by: (1) an inter parte Summons dated 20 June 2025 for continuation of the Injunction Order and seeking ancillary disclosure order against D ( Continuation Summons ); and (2) by inter partes Summons dated 20 June 2024 ( Disclosure Summons ) against the Bank seeking disclosure of certain documents in respect of D s Account with the Bank. Mr Lau, counsel, appeared on behalf of P. D and the Bank were all served the Summons but have not appeared. By letter dated 26 June 2025 to P s solicitors, the Bank has indicate no stance to the Disclosure Summons save would like more time to provide the documents requested. Discussion Re: Disclosure Summons The applicable principles for Norwich Pharmacal relief are well-settled. It is not a usual order and will not be lightly granted in the absence of powerful factors: It is made against an innocent party whose only involvement is to become mixed up in the tortious or wrongful activities of others; The wrongdoing exists only on the part of a person or persons against whom no relief may be sought at the stage of the application and
against whom there is probably insufficient evidence to found an action; There will usually be a legal relationship between the innocent person against whom a discovery order is sought and the alleged wrongdoer, and the relationship may involve strict duties to be observed on the innocent party s part. Any discovery to be made will involve a breach of confidentiality and may expose the innocent party to civil liability and possibly even criminal liability; and The court must accordingly balance the competing interests of the victim of the alleged wrongdoing and an innocent party caught up in the wrongdoing. See A Co v B Co [2002] 3 HKLRD 111 at 12 per Ma J (as he then was). In A Co v B Co at 13, the main requirements for Norwich Pharmacal relief were set out: There must be cogent and compelling evidence to demonstrate that serious tortious or wrongful activities have taken place (where fraud or similar serious allegations are made, the degree of proof must correspondingly be high); It must be clearly demonstrated that the order will or will very likely reap substantial and worthwhile benefits for the plaintiff, and where a tracing claim is likely to be made there must be a serious possibility that the discovery sought will either allow the plaintiff to preserve what may well be his assets or realistically lead to the discovery of such assets; and The discovery sought must not
be unduly wide, so an order must be specific and also restricted to those documents or those classes of documents that are necessary to enable the plaintiff to preserve or discover assets. The applicable principles governing an order under s.21 of Evidence Ordinance, Cap. 8 ( ) are also well-established. Although it has been said that such order is justified where the plaintiff seeks to trace funds which in equity belongs to him and of which there was strong evidence that he has been fraudulently deprived, there are 3 limits: Firstly, the plaintiff must demonstrate a real prospect that the information may lead to the location or preservation of assets to which he is making a proprietary claim; Secondly, the documents sought to be disclosed must be identified with some specificity as would be expected of a subpoena; and Thirdly, the court needs to balance the potential advantage against the detriment to the person against whom the order is sought, not merely in terms of costs but by way of invasion of privacy and requiring breach of obligations of confidence to others. See CTO (HK) Ltd v Li Man Chiu & Others [2002] 2 HKLRD 875, 12-13 per Deputy Judge Poon (as he then was); and Hwang Joon Sang v Golden Electronics Inc. (No 2) [2021] 2 HKLRD 87 at 8-9 per Coleman J. I am satisfied that the requirements whether under the Norwich Pharmacal jurisdiction or under s.21 of EO are made
out and it is appropriate for an order to be made in terms of the Disclosure Summons as amended by P and further amended by me. In the present case, P has made a proprietary claim to the Sum on the basis that it was the victim of a fraud. Given the learned Recorder in making the Injunction Order was plainly satisfied that there was a serious issue to be tried and good arguable case on the merits to grant the Injunction Order, he must have considered that there was prima face evidence to demonstrate that a serious tortious or wrongful activities have taken place. I have considered the skeleton submissions and evidence filed before the learned Recorder and am also so satisfied. P seeks the account opening documents, related supporting documents and details of all transactions in respect of D s Account from 20 May 2025 to date of order. I am further satisfied the information sought will reap substantial and worthwhile benefit to P to ascertain the whereabouts of the Sum or its traceable proceeds. There is a real prospect the information sought will lead to the location or preservation of assets to which P has made a proprietary claim and for steps to be taken to preserve P s monies. I am also satisfied that the discovery sought is specific and restricted to documents necessary to enable P to preserve or discover assets. It is limited to disclosure of documents from the date of
transfer from P s account to D s Account to date of the order. Re: Continuation Summons As I am satisfied that D has been properly served and D does not appear to contest the continuation of the Injunction Order, I will order the continuation of the Injunction Order until trial or further order of the court. I also accept as that the Mareva and the proprietary injunction is to be continued, it follows that the ancillary disclosure orders should be made in order to ensure the injunctions granted are effective to serve their purpose. As explained by DHCJ Winnie Tsui (as she then was) in Canton Plus Enterprise Limited & Anor v Tong Zhenjun & Ors [2021] HKCFI 181 at 10-11, a Mareva injunction is granted to protect a plaintiff from the risk of having nothing or not enough to enforce if the plaintiff succeeds in obtaining a judgment after trial. An ancillary disclosure order would enable the plaintiff to find out the whereabouts of the defendant s assets and take steps accordingly to make sure that those assets are effectively frozen. In the case of proprietary injunction, an ancillary disclosure order would enable the plaintiff to locate, trace and thus preserve and pursue assets which the plaintiff says it is beneficially his. Accordingly, I will make an order in terms of the Continuation Summons as amended by me. ( Grace Chow ) Deputy High Court Judge Mr Kevin Lau, instructed by Messrs W K To & Co. Solicitors, for the Plaintiff The Defendant was not represented and being absent The Bank was not represented and being absent -
PAGE
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T U V hTV` hf:~ hTV` yt&> yt&> yt&> yt&> yt&> ti]tR h 05 h Kz hvzj hI8j h.pz mH <nH sH <tH h.pz yt&> yt&> yt&> yt&> yt&> mH <nH sH <tH [Content_Types].xml _rels/.rels theme/theme/themeManager.xml K Y, sQ}# theme/theme/theme1.xml $O}) Xp90 +PHI| PP yu 9xu5 fs+W VF7H q=. 8}d- qyI@ j!Q_ jyV` |PZ+ T ""p < 4V O&x$ A8>v ;EUC n 8r *~P(5 .}x E /,EE\} theme/theme/_rels/themeManager.xml.rels 5 6?$Q K(M&$R(.1 [Content_Types].xmlPK _rels/.relsPK theme/theme/themeManager.xmlPK theme/theme/theme1.xmlPK theme/theme/_rels/themeManager.xml.relsPK <?xml version="1.0" encoding="UTF-8" standalone="yes"?> <a:clrMap xmlns:a="http://schemas.openxmlformats.org/drawingml/2006/main" bg1="lt1" tx1="dk1" bg2="lt2" tx2="dk2" accent1="accent1" accent2="accent2" accent3="accent3" accent4="accent4" accent5="accent5" accent6="accent6" hlink="hlink"
folHlink="folHlink"/> [Content_Types].xml dlyLho ;d]6 yJ.; _rels/.rels fLV:* ]m@= T;GI b9`5 drs/e2oDoc.xml ?8$y t(N* aTOR! 1'0Ro4 F9ks drs/downrev.xmlL 6#K)V [Content_Types].xmlPK _rels/.relsPK drs/e2oDoc.xmlPK drs/downrev.xmlPK [Content_Types].xml dlyLho ;d]6 yJ.; _rels/.rels fLV:* ]m@= T;GI b9`5 drs/e2oDoc.xml ~XMf #R+^ \w(Ljl f}#- e^NV 0?j [xF` @TeV ( P5 drs/downrev.xmlL Py9\ [Content_Types].xmlPK _rels/.relsPK drs/e2oDoc.xmlPK drs/downrev.xmlPK [Content_Types].xml dlyLho ;d]6 yJ.; _rels/.rels fLV:* ]m@= T;GI b9`5 drs/e2oDoc.xml ?8$y t(N* aTOR! 1'0Ro4 F9ks drs/downrev.xmlL 6#K)V [Content_Types].xmlPK _rels/.relsPK drs/e2oDoc.xmlPK drs/downrev.xmlPK [Content_Types].xml dlyLho ;d]6 yJ.; _rels/.rels fLV:* ]m@= T;GI b9`5 drs/e2oDoc.xml ~XMf #R+^ \w(Ljl f}#- e^NV 0?j [xF` @TeV ( P5 drs/downrev.xmlL Py9\ [Content_Types].xmlPK _rels/.relsPK drs/e2oDoc.xmlPK drs/downrev.xmlPK rg C& .YTVo ;~jH@ rg C Windows User Normal.dotm Windows User Microsoft Office Word Title pA~j{ pA~j{ <?xml version="1.0" encoding="UTF-8" standalone="no"?><b:Sources xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" SelectedStyle="\APASixthEditionOfficeOnline.xsl" StyleName="APA" Version="6"></b:Sources> <?xml version="1.0" encoding="UTF-8" standalone="no"?> <ds:datastoreItem ds:itemID="{DCD7B7CB-6CA8-419E-B5B0-E77144ABE0C3}" xmlns:ds="http://schemas.openxmlformats.org/officeDocument/2006/customXml"><ds:schemaRefs><ds:schemaRef ds:uri="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem> Microsoft Word 97-2003 Document MSWordDoc Word.Document.8
Case-aware research
Ask AI about this case
The judgment and available research above are public. New questions open in a separate private conversation grounded in this case.